Literature DB >> 11056828

Estimated prevalence of the seasonal subtype of major depression in a Canadian community sample.

A J Levitt1, M H Boyle, R T Joffe, Z Baumal.   

Abstract

OBJECTIVE: To examine estimates of lifetime prevalence of seasonal affective disorder (SAD) in Toronto, Ontario.
METHOD: Random telephone numbers were generated for the city of Toronto, and 781 respondents completed a telephone interview. Trained nonphysician interviewers conducted all interviews, which involved structured questions for diagnosing major depression. Patterns of symptom change across seasons were evaluated to establish a diagnosis of SAD according to DSM-III-R criteria.
RESULTS: Correcting for sex and age, the prevalence of SAD defined by DSM-III-R criteria was 2.9% (95% CI, 1.7% to 4.0%), and the overall lifetime prevalence of major depression in the sample was 26.4% (95% CI, 23.3% to 29.4%). Some subjects were contacted for a follow-up interview conducted in person; the positive predictive value for the diagnosis of major depression for the telephone interview was 100%, and the negative predictive value was 93%.
CONCLUSIONS: The seasonal subtype of depression represents 11% of all subjects with major depression, suggesting that SAD is a significant public health concern. The telephone interview demonstrated adequate reliability, indicating that it is appropriate for epidemiological surveys of this nature.

Entities:  

Mesh:

Year:  2000        PMID: 11056828     DOI: 10.1177/070674370004500708

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN: 0706-7437            Impact factor:   4.356


  17 in total

1.  Winter needn't be the SAD season.

Authors:  E Weir
Journal:  CMAJ       Date:  2001-01-23       Impact factor: 8.262

2.  Antepartum depression severity is increased during seasonally longer nights: relationship to melatonin and cortisol timing and quantity.

Authors:  Charles J Meliska; Luis F Martínez; Ana M López; Diane L Sorenson; Sara Nowakowski; Daniel F Kripke; Jeffrey Elliott; Barbara L Parry
Journal:  Chronobiol Int       Date:  2013-09-03       Impact factor: 2.877

3.  Nutritional interventions for treatment of seasonal affective disorder.

Authors:  Lawrence A Palinkas
Journal:  CNS Neurosci Ther       Date:  2010       Impact factor: 5.243

4.  Serum lipid levels in seasonal affective disorder.

Authors:  Edda Pjrek; Dietmar Winkler; David W Abramson; Anastasios Konstantinidis; Jürgen Stastny; Matthäus Willeit; Nicole Praschak-Rieder; Siegfried Kasper
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-12-05       Impact factor: 5.270

5.  Delayed sleep phase syndrome is related to seasonal affective disorder.

Authors:  Heon-Jeong Lee; Katharine M Rex; Caroline M Nievergelt; John R Kelsoe; Daniel F Kripke
Journal:  J Affect Disord       Date:  2011-05-20       Impact factor: 4.839

6.  Seasonality of depression referrals in older people.

Authors:  Lucy Elizabeth Holloway; Sandra Evans
Journal:  Community Ment Health J       Date:  2013-08-20

7.  Plasma Phosphatidylethanolamine and Triacylglycerol Fatty Acid Concentrations are Altered in Major Depressive Disorder Patients with Seasonal Pattern.

Authors:  Yurika Otoki; Marie Hennebelle; Anthony J Levitt; Kiyotaka Nakagawa; Walter Swardfager; Ameer Y Taha
Journal:  Lipids       Date:  2017-04-24       Impact factor: 1.880

Review 8.  Long-term and preventative treatment for seasonal affective disorder.

Authors:  Asa Westrin; Raymond W Lam
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

9.  Seasonal variation of depressive symptoms in unipolar major depressive disorder.

Authors:  Bryan S Cobb; William H Coryell; Joseph Cavanaugh; Martin Keller; David A Solomon; Jean Endicott; James B Potash; Jess G Fiedorowicz
Journal:  Compr Psychiatry       Date:  2014-08-04       Impact factor: 3.735

Review 10.  Epidemiologic heterogeneity of common mood and anxiety disorders over the lifecourse in the general population: a systematic review.

Authors:  Arijit Nandi; John R Beard; Sandro Galea
Journal:  BMC Psychiatry       Date:  2009-06-01       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.